City

Bronx (1)

Chicago (1)

Cleveland (1)

Dallas (1)

Detroit (1)

Fairfax (1)

Oklahoma City (1)

Santa Monica (1)

Tampa (1)

Condition

Advanced Solid Neoplasm (2)

Aggressive Non-Hodgkin Lymphoma (1)

Recurrent Solid Neoplasm (1)

Refractory Mantle Cell Lymphoma (1)

T-Cell Non-Hodgkin Lymphoma (1)

Unresectable Solid Neoplasm (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Millennium Pharmaceuticals, Inc. (1)

Northwestern University (1)

Collaborator

AbbVie (1)

Bristol-Myers Squibb (1)

National Cancer Institute (NCI) (1)

Intervention

carboplatin (1)

docetaxel (1)

laboratory biomarker analysis (1)

nivolumab (1)

paclitaxel (1)

pevonedistat (1)

pharmacological study (1)

veliparib (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

Advanced Solid Neoplasm

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Solid Tumor Trial in United States (Pevonedistat, Docetaxel, Carboplatin)

Completed

Advanced Solid Neoplasm

Pevonedistat
+3 more

Santa Monica, California
+7 more

Jun 22, 2021

Advanced Solid Tumor, Aggressive Non-Hodgkin Lymphoma, Recurrent Solid Tumor Trial in Chicago (other, biological, drug)

Unknown status

Has Results

Advanced Solid Neoplasm
+5 more

Laboratory Biomarker Analysis
+3 more

Chicago, Illinois

Northwestern University

Oct 27, 2020